© 2001 by the American Diabetes Association, Inc.
Lack of Compliance With Home Blood Glucose Monitoring Predicts Hospitalization in DiabetesDepartment of Medicine/Endocrinology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico Home capillary blood glucose (CBG) monitoring is the standard of care for patients with diabetes (1,2). Patients with type 1 diabetes should monitor their CBG concentration at least three or four times daily, and patients with type 2 diabetes should probably monitor their CBG concentration at least twice a day (1). Nevertheless, up to 67% of patients with diabetes fail to routinely monitor their CBG levels (3). Although the relationship between rigorous home blood glucose monitoring and improved glycemic control is well-established, determinants of compliance with home blood glucose monitoring recommendations are not known. Reported here are the results of a marketing survey exploring attitudes and behaviors surrounding compliance with home CBG monitoring.
My group has previously published a study examining the efficacy of a laser skin perforator for the attainment of capillary blood samples for home CBG monitoring (4). In response to the large number of telephone inquiries received, the manufacturer of this device (Lasette Laser Skin Perforator; Cell Robotics, Albuquerque, NM) mailed out a brief questionnaire examining current home blood glucose monitoring practices and attitudes about this activity ACKNOWLEDGMENTS FOOTNOTES References
This article has been cited by other articles:
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||